Bryce P. Portier, Ph.D. - Publications
Affiliations: | 2006 | University of Texas Medical Branch, Galveston, TX |
Area:
Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Fiskus W, Sharma S, Qi J, Valenta JA, Schaub LJ, Shah B, Peth K, Portier BP, Rodriguez M, Devaraj SG, Zhan M, Sheng J, Iyer SP, Bradner JE, Bhalla KN. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. Molecular Cancer Therapeutics. 13: 1142-54. PMID 24435446 DOI: 10.1158/1535-7163.Mct-13-0770 | 0.305 | |||
2006 | Portier BP, Taglialatela G. Bcl-2 localized at the nuclear compartment induces apoptosis after transient overexpression. The Journal of Biological Chemistry. 281: 40493-502. PMID 17090549 DOI: 10.1074/Jbc.M606181200 | 0.492 | |||
2006 | Portier BP, Ferrari DC, Taglialatela G. Rapid assay for quantitative measurement of apoptosis in cultured cells and brain tissue. Journal of Neuroscience Methods. 155: 134-42. PMID 16563518 DOI: 10.1016/J.Jneumeth.2006.01.024 | 0.432 | |||
2004 | Massaad CA, Portier BP, Taglialatela G. Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. The Journal of Biological Chemistry. 279: 54470-8. PMID 15471874 DOI: 10.1074/Jbc.M407659200 | 0.457 | |||
Show low-probability matches. |